Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges

被引：30
|
作者：
Maeda, Tadao [1 ,2 ,3 ]
Mandai, Michiko [1 ,2 ,3 ]
Sugita, Sunao [1 ,2 ,3 ,4 ]
Kime, Cody [3 ,5 ]
Takahashi, Masayo [1 ,2 ,3 ,4 ]
机构：
[1] Kobe City Eye Hosp, Res Ctr, Kobe, Hyogo 6500047, Japan
[2] Kobe City Eye Hosp, Dept Ophthalmol, Kobe, Hyogo 6500047, Japan
[3] RIKEN Ctr Biosyst Dynam Res, Lab Retinal Regenerat, Kobe, Hyogo 6500047, Japan
[4] Vis Care Inc, Kobe, Hyogo 6500047, Japan
[5] Trans Ova Genet, Sioux Ctr, IA USA
来源：
TRENDS IN MOLECULAR MEDICINE | 2022年 / 28卷 / 05期
关键词：
PIGMENT EPITHELIAL-CELLS; IMMUNE PRIVILEGE; IPS CELLS; TRANSCRIPTION FACTORS; MOUSE FIBROBLASTS; DIRECT CONVERSION; VISUAL FUNCTION; NEURAL RETINA; TRANSPLANTATION; SHEETS;
D O I：
10.1016/j.molmed.2022.03.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Stem cell-based therapy for retinal degeneration is transitioning from the research stage to the clinical stage and is being developed as a treatment across the globe. In clinical studies on induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) transplantation, the safety of the technique has started to clarify, and clinical study on further advances such as the long desired transplantation of iPSC-derived retina to treat retinitis pigmentosa (RP) has begun. Ophthalmologists are now working closely with basic researchers to incorporate new technology areas with a synergy that is anticipated to realize the practical application of stem cell-based therapy for retinal degeneration.
引用
收藏
页码：388 / 404
页数：17
相关论文
共 50 条
  • [1] Editorial: Stem Cell-Based Therapy in Retinal Degeneration
    Huang, Xiaona
    Gao, Hui
    Xu, Haiwei
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [2] Pluripotent Stem Cell-Based Cancer Therapy: Promise and Challenges
    Sharkis, Saul J.
    Jones, Richard J.
    Civin, Curt
    Jang, Yoon-Young
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (127)
  • [3] Pluripotent Stem Cell-Based Cell Therapy- Promise and Challenges
    Yamanaka, Shinya
    CELL STEM CELL, 2020, 27 (04) : 523 - 531
  • [4] Progress of stem/progenitor cell-based therapy for retinal degeneration
    Tang, Zhimin
    Zhang, Yi
    Wang, Yuyao
    Zhang, Dandan
    Shen, Bingqiao
    Luo, Min
    Gu, Ping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [5] Progress of stem/progenitor cell-based therapy for retinal degeneration
    Zhimin Tang
    Yi Zhang
    Yuyao Wang
    Dandan Zhang
    Bingqiao Shen
    Min Luo
    Ping Gu
    Journal of Translational Medicine, 15
  • [6] The prospect of pluripotent stem cell-based therapy
    Borisenko G.G.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2009, 3 (3) : 248 - 258
  • [7] Induced pluripotent stem cell-based therapy for age-related macular degeneration
    Bracha, Peter
    Moore, Nicholas A.
    Ciulla, Thomas A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (09) : 1113 - 1126
  • [8] Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration
    Liu, Hui
    Lu, Shuaiyan
    Chen, Ming
    Gao, Na
    Yang, Yuhe
    Hu, Huijuan
    Ren, Qing
    Liu, Xiaoyu
    Chen, Hongxu
    Zhu, Qunyan
    Li, Shasha
    Su, Jianzhong
    STEM CELL REVIEWS AND REPORTS, 2024, 20 (06) : 1459 - 1479
  • [9] Cell therapy for macular degeneration—first phase Ⅰ/Ⅱ pluripotent stem cell-based clinical trial shows promise
    CHEN ZhiGuo
    ZHANG YAlex
    Science China(Life Sciences), 2015, 58 (01) : 119 - 120
  • [10] Cell therapy for macular degeneration—first phase Ⅰ/Ⅱ pluripotent stem cell-based clinical trial shows promise
    CHEN ZhiGuo
    ZHANG Y.Alex
    Science China(Life Sciences), 2015, (01) : 119 - 120
12345